Stockholm, December 16, 2014
Nasdaq (Nasdaq: NDAQ) announced that C-RAD AB (short name: CRAD B), a Small Cap company within the Health care sector, has started trading of its shares on the main market of Nasdaq Stockholm. C-RAD was previously listed on First North and is, including switches, the 24th company to list at Nasdaq’s Nordic main markets in 2014 (Nasdaq Stockholm; Helsinki; Copenhagen; and Iceland).
C-RAD develops innovative solutions for use in advanced radiation therapy. The company offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is located in Uppsala, Sweden. Founded in 2004, C-RAD’s business originates from research and development at Karolinska Institutet in Solna, Sweden. For more information, please visit www.c-rad.com
Opening the market, from the left, Erling Tomasson, CFO and Tim Thurn, CEO at C-RAD.
Interview with the CEO, Tim Thurn.
C-RAD together with their advisers from Erik Penser Bank and the Nasdaq team.